We anticipate there will be some policy changes and important issues to watch with the inauguration of the 47th president of the United States. Vizient’s office of public policy and government relations monitors, educates and advocates on key items of interest. They share informative updates, comment on proposed rules from agencies like the Centers for Medicare and Medicaid Services and work with Congress on legislative priorities. Jenna Stern, Associate Vice President of Regulatory Affairs and Public Policy at Vizient joins Program Host Carolyn Liptak to discuss the change over.

Guest speakers:

Jenna Stern

Associate Vice President of Regulatory Affairs and Public Policy

Vizient

Host:

Carolyn Liptak, MBA, RPh

VerifiedRx Host

Show Notes:

[00:56-01:15] Jenna’s background

[01:16-02:38] Anticipation in DC since November

[02:39-04:26] What we should anticipate with the new Congress

[04:27-08:10] Trade and Tariffs

[08:11-10:37] What we should anticipate with the Executive Branch

[10:38-12:48] Policies to watch during transition

[12:48-13:34] Where listeners go for more information

[13:34-16:12] What issues are important to the new Congress

Links | Resources:

Vizient Public Policy and Government Relations

Vizient advocacy letters and Congressional statements

Legislative and regulatory summaries

China Tariffs document

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Spotify

Android

RSS Feed

Human rabies cases are fortunately rare in the US. Access to pre- and post-exposure prophylaxis, and domestic animal vaccination programs, drive this public health success. This comes at a financial and human resources cost. Dr. Kyle Weant, clinical assistant professor and an emergency medical clinical pharmacy specialist at the University of South Carolina College of Pharmacy and Dr. Philippe Mentler, senior consulting director, join host Gretchen Brummel to discuss the use of rabies immune globulin and rabies vaccine in patients who have been exposed and provide treatment pearls for frontline pharmacy practioners.

Guest speakers:

Kyle Weant, PharmD, BCPS, BCCCP, FCCP

Clinical Assistant Professor and an Emergency Medical Clinical Pharmacy Specialist

University of South Carolina College of Pharmacy

Philippe Mentler, PharmD, BCPS

Senior Consulting Director

Vizient

Host:

Gretchen Brummel, PharmD, BCPS

Show Notes:

[00:54-01:17] Kyle’s background information

[01:18-03:31] Rabies as a disease

[03:32-05:13] Public Awareness

[05:14-07:06] Options right now for post-exposure prophylaxis

[07:07-10:01] Thoughts on dose rounding

[10:02-10:13] Is rabies immunoglobulin considered an essential medication that everyone should stock in their hospital pharmacy

[10:14-11:30] Who should be administering these drugs? And who's ensuring follow up of these patients?

[11:31-14:31] Potential pitfalls in patient management

[14:32-18:12] What should our frontline pharmacy staff know about post-exposure prophylaxis

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Spotify

Android

RSS Feed

Data dominate nearly every sector and drug shortages are an area to leverage data solutions. Stephen Colvill, Senior Policy Advisor for Medical Supply Chains, The White House Domestic Policy Council and Dr Nikola Markoski, Vizient Manager of Pharmacy Analytics and Clinical Insights, join host Gretchen Brummel to explore novel approaches and future implications for data use cases in drug shortages.

Guest speakers:

Stephen Colvill

Senior Policy Advisor for Medical Supply Chains, Domestic Policy Council The White House, Domestic Policy Council

This podcast was recorded in December 2023 prior to Stephen joining the federal government. The opinions expressed are the author’s own and do not necessarily reflect the views of the United States government or any agency thereof.

At the time of recording, Stephen was Executive Director of RISCS and Assistant Research Director at the Duke-Margolis Institute for Health Policy.

Nikola Markoski, PharmD, MBA, DPLA

Manager of Pharmacy Analytics and Clinical Insights

Vizient

VerifiedRx Host:

Gretchen Brummel, PharmD, BCPS

Show Notes:

[00:36-02:23] Guest’s background information

[02:24-05:44] How using data can change the discussion of drug shortages

[05:45-09:23] Approaches that have been attempted so far in the data space

[09:24-12:01] Where things are going in the future

[12:02-15:23] How we get everybody on the same page

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Spotify

Android

RSS Feed